title: Immunization of babies born to HBsAg positive mothers: An audit on the delivery and completeness of follow up in Norfolk and Suffolk, United Kingdom.
abstract: Perinatal transmission of hepatitis B infection has increased in the UK over the last decade. Routine antenatal screening of pregnant mothers (based on HBsAg) provides an effective means to identify 'at risk' babies. Follow up of babies born to infected mothers involves 4 doses of vaccination and/or a single dose of HBIG at birth. In this study we report the outcome of follow up of babies born to infected mothers over a 5 y period. One hundred sixty-three babies born to HBsAg positive mothers were followed up to ascertain the completeness for immunization and serological testing. Vaccination completion was 99.4% (162 of babies) at birth (1st dose), 95.6% (152 babies) for the second dose (at 1st month), 94.3 % (148 babies) for the 3rd dose (at 2nd month) and 83.4% (106 babies) for the 4th dose (at 12 months). Additionally, at 12 months 29.9% (38) of babies had their blood tested serologically to ascertain infection status; all babies receiving antigen testing were HBsAg negative. The overall vaccination coverage was good, although there is scope to improve the coverage of 4th dose. However, the proportion of children who were serologically tested for surface antigen at 12 months was considerably lower and there is a greater need to test babies concurrently at the time of giving the 4(th) dose. The proposed dried blood spot testing which will be rolled out from September 2014 should address this issue.
authors: a Speciality Registrar in Public Health; Anglia Health Protection Team; Anglia and Essex Centre ; Public Health England; London , UK.
authors: Stuart
authors: S
authors: Keeble
authors: Jane
authors: J
authors: Quested
authors: Deborah
authors: D
authors: Barker
authors: Abina
authors: A
authors: Varadarajan
authors: Ananda Giri
authors: AG
authors: Shankar
mesh_terms: D005260:Female; D006302:Health Services Research; D006509:Hepatitis B / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000008:administration & dosage* / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage* / Q000276:immunology; D006801:Humans; D007114:Immunization / Q000379:methods* / Q000706:statistics & numerical data; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D008297:Male; D006113:United Kingdom
chemical_list: D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines
keywords: AHPT, Anglia Health Protection Team; CHIS, Child Health Information System; DBS, Dried Blood Spot; DNA, Deoxyribonucleic acid; GP, General Practitioner; HBIG, Hepatitis B Immunoglobulin; HBV, Hepatitis B Virus; HBeAg, Hepatitis B ‘e’ Antigen; HBsAg, Hepatitis B surface Antigen; HepB, Hepatitis B; Hepatitis B; Immunization; NSC, Norfolk, Suffolk and Cambridgeshire; UK, United Kingdom; United Kingdom; anti-HBe, antibodies against hepatitis B ‘e’ antigen; baby vaccinations; perinatal transmission